Results

Total Results: 2,279 records

Showing results for "factor".

121. PowerPoint Presentation (ppt file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Example: Slice thickness is a relevant factor for assessing the applicability/accuracy of cardiac magnetic … Principle 1: Identify Important Contextual Factors (2 of 10) The first contextual factor is spectrum … Principle 1: Identify Important Contextual Factors (3 of 10) The second contextual factor concerns where … Principle 1: Identify Important Contextual Factors (4 of 10) The third contextual factor concerns the … Principle 1: Identify Important Contextual Factors (9 of 10) The sixth and final contextual factor to

122. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
     January 01, 2008 - )  Anemia in patients with end-stage renal disease (ESRD) is a risk factor for increased mortality

123. Atrial-Fibrillation-Ablation Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
     May 16, 2013 - recurrence rates, three studies showed that gender was either a significant predictor or protective factor … vs. no AF recurrence Female gender: HR=0.092, 95% CI: 0.022, 0.386 (female gender as a protective factor … AF recurrence) HR=0.58, 95% CI: 0.36, 0.94 [MVA] (absence of coronary disease as a protective factor … No AF termination 38(5) vs. 44(8); smaller LA diameter [mm] as a protective factor against AF, MVA … against AF recurrence, MVA) OR=0.051, 95% CI: 0.008, 0.338 (PAF as a protective factor against

124. Editorial. Methods Guide for Authors of Systematic Reviews of Medical Tests: A Collaboration Between the Agency for Healthcare Research and Quality (AHRQ) and the Journal of General Internal Medicine | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guide-editorial/methods
     December 01, 2019 - fields of general internal medicine, family practice, nursing, and mental health, the average impact factor … for systematic reviews was 26.5. 1 In contrast, the mean impact factor for the top 40 general medical

125. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - molecular weight heparin (LMWH), vitamin K antagonists (VKA), antithrombin III-mediated selective factor … Xa inhibitors, direct factor Xa inhibitors (FXaI), bivalent and univalent direct thrombin inhibitors … Mechanical prophylaxis aims to minimize stasis, the principal putative factor resulting in venous thrombosis … the searches from the 2012 VTE report and added additional 4 terms for new treatments (e.g., factor … VIII inhibitors (FEI), factor Xa inhibitors (FXaI), factor XI inhibitors (FXIi), direct thrombin inhibitors

126. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
     June 01, 2017 - molecular weight heparin (LMWH), vitamin K antagonists (VKA), antithrombin III-mediated selective factor … Xa inhibitors, direct factor Xa inhibitors (FXaI), bivalent and univalent direct thrombin inhibitors … Mechanical prophylaxis aims to minimize stasis, the principal putative factor resulting in venous thrombosis … the searches from the 2012 VTE report and added additional 4 terms for new treatments (e.g., factor … VIII inhibitors (FEI), factor Xa inhibitors (FXaI), factor XI inhibitors (FXIi), direct thrombin inhibitors

127. Digestive Diseases | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/digestive-diseases?page=1
     March 14, 2012 - Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor

128. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/tinnitus_research-protocol.pdf
     February 22, 2012 - traditional Chinese medicinal treatment used to increase blood flow, inhibit the platelet-activating factor … basis of the design or analysis a) study controls for _______________ (Select the most important factor … control for a second important factor.) … ) * b) study controls for any additional factor * (This criteria could be modified to indicate specific … - Appropriate methods are used if imputation is used for missing prognostic factor ☐

129. Procalcitonin for Diagnosis and Management of Sepsis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/procalcitonin/research-protocol
     December 01, 2019 - assessed based on an approach applied to a systematic review of testing for human epidermal growth factor … would be a trial in which randomized assignment to treatment groups would be stratified by a predictive factor … level or in which patients were randomized to receive treatment guided by a predictive factor or not … adequately powered stratified randomization would allow valid inferences of treatment by predictive factor … efficacy of two treatments, whereas single-arm studies can only assess the association between predictive factor

130. Methods Guide for Medical Test Reviews - Editorial (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guide-editorial_methods.pdf
     July 01, 2012 - fields of general internal medicine, family practice, nursing, and mental health, the average impact factor … for systematic reviews was 26.5.1 In contrast, the mean impact factor for the top 40 general medical

131. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
     January 01, 2007 - In addition to being the number one attributable risk factor for death throughout the world, hypertension … Risk factor reduction and other Moderate (lipid There were no consistent differential effects of ACEIs

132. Cystic-Fibrosis-Hgh Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
     August 01, 2012 - safety concerns • Evaluation of the safety and efficacy of recombinant human Insulin-like Growth Factor-I … However, we also accepted for review studies of insulin-like growth factor I for the treatment of cystic … [IGF-I] increases over 100 ng/ml or insulin –like growth factor binding protein-3 [(IGFBP-3] decreases … I; IGFBP insulin-like growth factor binding protein; LBM lean body mass; MHRA Medicines and Healthcare … [IGF-I] increases over 100 ng/ml or insulin –like growth factor binding protein-3 [(IGFBP-3] decreases

133. Comparative Effectiveness of Venous Thromboembolism (VTE) Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
     December 01, 2019 - injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … injectable low molecular weight heparins (LMWH), injectable unfractionated heparin, injectable or oral factor … what is the relative impact of injectable antithrombotic agents (LMWH vs. unfractionated heparin vs. factor … Factor Xa Inhibitors Rivaroxiban (Xarelto®) Ortho-McNeil-Janssen Investigational drug, not yet … methods of thromboprophylaxis versus control or compare injectable antithrombotic agents (LMWH, UFH, factor

134. Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research
     December 01, 2019 - No difference in treatment response was found between the combination of an anti-tumor necrosis factor

135. Simulation-Based Comparison of Methods for Meta-Analysis of Proportions and Rates | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/metanalysis-proportion-rate-comparison/research
     November 01, 2017 - approximate methods that require continuity corrections, as the arbitrary choice of the correction factor

136. Ebell_Presentation_REVISED_FINAL (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/use_of_handheld_ebell_presentation.pdf
     January 01, 2009 -  based  on:   o Counting  (i.e.  1  point  per  clinical  finding  or  risk  factor

137. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0320_06-17-2009.pdf
     January 01, 2009 - Can FLC reliably be used as an independent risk factor for progression to MM in MGUS patients?

138. VTE Surveillance Assessment_49_low_SPI (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
     December 01, 2012 - Classes include oral antiplatelet agents, injectable LMWHs, injectable UFH, injectable or oral factor … As such, it is likely inferior to factor Xa inhibitors in the balance of benefits and harms as well … UFH vs. factor Xa inhibitors vs. … A dose- ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous … UFH vs. factor Xa inhibitors vs.

139. Blood Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/blood-disorders
     July 26, 2016 - Review Archived June 1, 2010 Comparative Effectiveness of In-Hospital Use of Recombinant Factor

140. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - Oxytocin factor - 30 ml nasal spray. [internet]. Amazon.com, Inc. … Available: http://www.amazon.com/Oxytocin- Factor-30-Nasal-Spray/dp/B007K8LTD2. 42. … Oxytocin factor. [internet]. ABC Nutriceuticals [accessed 2013 Nov 21]. [2 p]. … startswith=oxytocin&x=0&y=0 http://www.fda.gov/ http://www.amazon.com/Oxytocin-Factor-30-Nasal-Spray/ … dp/B007K8LTD2 http://www.amazon.com/Oxytocin-Factor-30-Nasal-Spray/dp/B007K8LTD2 http://tryoxytoday.com